Gastrointestinal distress Semaglutide can cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, stomach pain, bloating, belching, loss of appetite, and upset stomach
GLP-1 Medications and Mental Health: What Weve Learned Since 2023 December 26, 2025 | Updated from our original September 2023 post In September 2023, I wrote about semaglutide (commonly known by brand names such as Wegovy and Ozempic) in response to a growing number of client questions
Stopping semaglutide abruptly often leads to rapid rebound, with reports of a 50% increase in appetite within the first week, and about 70% of patients experience weight regain after abrupt discontinuation
Wegovy and Ozempic: The Brand-Name Path Both are FDA-approved injectable forms of semaglutide manufactured at Novo Nordisk facilities under FDA oversight
Was very comfortable and at ease